98-73-7|4-tert-Butylbenzoic acid - Shanghai Canbi Pharma Ltd.

Current Location
Home Products
detail

4-tert-Butylbenzoic acid | CAS:98-73-7

4-tert-Butylbenzoic acid

Name：4-tert-Butylbenzoic acid
CAS：98-73-7
Synonyms：PTBBA
Molecular Formula：C₁₁H₁₄O₂
Molecular Weight：178.23
EINESC：202-696-3

Description

Properties

Melting point	164-167 ºC
Water Solubility	0.07 g/L (20 ºC)
Flash point	180 ºC

Safety

Symbol(GHS)	T;N
Hazard Codes	R20/22;R24;R48/20/21/22;R51/53;R
SDS/MSDS	S28A;S36/37/39;S45;S61

SDS

Source	SDS/MSDS Samples
没有数据	没有数据

Synthetic Route

Name	CAS

Articles

Peer-Reviewed Papers

mTOR inhibition overcomes primary and acquired resistance to Wee1 inhibition by augmenting replication stress in epithelial ovarian cancers.Fuxia Li et al.American journal of cancer research, 10(3), 908-924 (2020-04-09) Distinct roles of RalA and RalB in the progression of cytokinesis are supported by distinct RalGEFs.Ilaria Cascone et al.The EMBO journal, 27(18), 2375-2387 (2008-08-30) Central memory CD4+ T cells are preferential targets of double infection by HIV-1.Aiman A Haqqani et al.Virology journal, 12, 184-184 (2015-11-13) FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC.Francesco Morra et al.Oncotarget, 6(14), 12697-12709 (2015-04-18) SAMHD1 Modulates Early Steps during Human Cytomegalovirus Infection by Limiting NF-κB Activation.Eui Tae Kim et al.Cell reports, 28(2), 434-448 (2019-07-11) mTOR Overcomes Multiple Metabolic Restrictions to Enable HIV-1 Reverse Transcription and Intracellular Transport.Harry E Taylor et al.Cell reports, 31(12), 107810-107810 (2020-06-25)

Remarks

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

Name	CAS

Description

Properties

Safety

SDS

Related Products

Related News